FARMACIA

Scope & Guideline

Connecting Researchers to the Pulse of Pharmaceutical Innovation.

Introduction

Welcome to the FARMACIA information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of FARMACIA, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageRumanian
ISSN0014-8237
PublisherSOC STIINTE FARMACEUTICE ROMANIA
Support Open AccessNo
CountryRomania
TypeJournal
Convergefrom 1945 to 1946, from 1973 to 1987, 2003, from 2008 to 2024
AbbreviationFARMACIA / Farmacia
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI 020956, ROMANIA

Aims and Scopes

The journal 'FARMACIA' focuses on the multifaceted domain of pharmaceuticals, including drug development, therapeutic effects, and the application of natural products. It aims to provide a platform for innovative research that bridges basic science and clinical practice, with a particular emphasis on the pharmacological and therapeutic potential of both synthetic and natural compounds.
  1. Pharmaceutical Research and Drug Development:
    The journal emphasizes rigorous research related to the development, formulation, and optimization of pharmaceutical products, exploring various methodologies including in vitro and in vivo studies.
  2. Natural Products and Phytochemistry:
    There is a strong focus on the exploration of natural products, particularly plant-derived compounds, assessing their pharmacological properties, safety, and efficacy in various therapeutic contexts.
  3. Clinical Pharmacology and Therapeutics:
    FARMACIA publishes studies that investigate the clinical applications of drugs, including efficacy and safety assessments, medication adherence, and the role of pharmacists in patient care.
  4. Pharmacovigilance and Drug Safety:
    The journal covers topics related to the monitoring of drug effects, adverse reactions, and the importance of pharmacovigilance in ensuring patient safety.
  5. Innovative Drug Delivery Systems:
    Research on novel drug delivery mechanisms, including nanoparticles and other advanced formulations, is a recurring theme, aimed at improving therapeutic outcomes.
  6. Interdisciplinary Approaches:
    FARMACIA promotes interdisciplinary research that integrates various fields such as biochemistry, molecular biology, and clinical practices, addressing complex health issues.
The journal 'FARMACIA' is witnessing a surge in interest in several emerging themes that reflect the evolving landscape of pharmaceutical research. These trends indicate a shift towards innovative and integrative approaches in drug development and therapeutics.
  1. Antimicrobial Resistance and Novel Antimicrobials:
    In light of the global health crisis posed by antimicrobial resistance, research focused on novel antimicrobial agents and their mechanisms of action is gaining traction, highlighting the urgency for new therapeutic strategies.
  2. Nanotechnology in Drug Delivery:
    The application of nanotechnology in drug formulation and delivery systems is increasingly prominent, showcasing innovative methods to enhance drug efficacy and bioavailability.
  3. Integrative Approaches to Health (One Health Concept):
    Research integrating pharmacology with environmental and health sciences, particularly through the One Health framework, emphasizes holistic approaches to health solutions and disease prevention.
  4. Phytopharmacology and Bioactive Compounds:
    There is a rising interest in the pharmacological evaluation of phytochemicals, focusing on their therapeutic potential and mechanisms of action in treating various diseases.
  5. Patient-Centered Pharmacotherapy:
    Research emphasizing patient adherence, satisfaction, and the role of pharmacists in personalized medicine is becoming increasingly significant, reflecting a shift towards patient-centered care.
  6. Digital Health and Pharmacovigilance:
    The intersection of digital health technologies and pharmacovigilance is emerging as a critical area, especially in monitoring drug safety and effectiveness in real-world settings.

Declining or Waning

While 'FARMACIA' continues to thrive in several research areas, certain themes have shown a decline in prominence over recent years. These waning scopes reflect shifting interests within the pharmaceutical research community.
  1. Traditional Medicine and Folk Remedies:
    Research focused on traditional medicine practices and folk remedies has decreased, possibly due to a growing emphasis on evidence-based approaches and clinical trials.
  2. Basic Science without Direct Clinical Application:
    Studies that are purely theoretical or basic science without immediate clinical implications appear less frequently, as the journal seeks to prioritize research with tangible therapeutic relevance.
  3. General Reviews on Well-Established Drugs:
    There is less emphasis on broad reviews of well-established drugs, as the journal pivots towards more novel compounds and emerging therapeutic strategies.
  4. Epidemiological Studies without Pharmacological Focus:
    Epidemiological research that does not directly connect to pharmacological interventions or drug efficacy is becoming less common, reflecting a trend towards more actionable research outcomes.

Similar Journals

PHARMAZIE

Advancing pharmaceutical knowledge since 1947.
Publisher: AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBHISSN: 0031-7144Frequency: 12 issues/year

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Bridging research and real-world applications in pharmacology.
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0031-6903Frequency: 12 issues/year

YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

INDIAN JOURNAL OF PHARMACOLOGY

Transforming clinical practices with groundbreaking pharmacological research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0253-7613Frequency: 6 issues/year

INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.

Pharmaceutical Sciences

Bridging research and practice to transform healthcare.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

Journal of Pharmaceutical Health Care and Sciences

Enhancing global health through open access pharmaceutical knowledge.
Publisher: BMCISSN: 2055-0294Frequency: 1 issue/year

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

Turkish Journal of Pharmaceutical Sciences

Advancing Pharmaceutical Knowledge for Global Health
Publisher: GALENOS PUBL HOUSEISSN: 1304-530XFrequency: 6 issues/year

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.

Iranian Journal of Pharmaceutical Research

Exploring innovative solutions in pharmaceutical sciences.
Publisher: BRIEFLANDISSN: 1735-0328Frequency: 4 issues/year

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

PHARMACEUTICAL CHEMISTRY JOURNAL

Exploring New Frontiers in Pharmaceutical Chemistry.
Publisher: SPRINGERISSN: 0091-150XFrequency: 12 issues/year

Pharmaceutical Chemistry Journal is a pivotal publication in the field of pharmaceutical sciences, renowned for its in-depth articles and research findings. Published by Springer in the United States, this journal provides a crucial platform for researchers, students, and professionals dedicated to advancing drug discovery and pharmacology. With an ISSN of 0091-150X and an E-ISSN of 1573-9031, this journal has consistently aimed to promote scholarly communication and innovation within its scope since its inception in 1967. Despite its current Category Quartiles ranking of Q4 in both Drug Discovery and Pharmacology, the journal remains a valuable resource for disseminating new ideas and findings that contribute to the scientific community. Researchers benefit from the journal's commitment to high-quality peer-reviewed content, even in an environment where open access options are currently not available. As the field evolves, the Pharmaceutical Chemistry Journal continues to play an important role in shaping future advancements in drug development and safety.

PHARMACIA

Empowering innovation in pharmacy and pharmacology.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

SCIENTIA PHARMACEUTICA

Elevating the discourse in pharmacology and pharmaceutics.
Publisher: MDPIISSN: Frequency: 4 issues/year

SCIENTIA PHARMACEUTICA, published by MDPI in Switzerland, is a leading open access journal dedicated to advancing the field of pharmaceutical sciences since 2006. With a focus on pharmacology, toxicology, and pharmaceutics, this journal plays a pivotal role in disseminating high-quality research and innovative findings. It boasts an impressive impact factor and is ranked in the second quartile (Q2) for Pharmaceutical Science, signifying its influence within the academic community, aided by a Scopus ranking of 74 out of 183 journals in the same category. SCIENTIA PHARMACEUTICA invites original research articles, reviews, and notes that contribute to the understanding and development of pharmaceutical science, making it an essential resource for researchers, professionals, and students alike seeking to stay at the forefront of this continuously evolving field. For those interested in broadening their knowledge and sharing insights, the journal ensures wide accessibility, supporting the open access model for maximum outreach.